Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01890824 · ClinicalTrials.gov registry record
Fat Metabolism Following Chemotherapy in Breast Cancer
A clinical trial, sponsored by Texas A&M University.
- Terminated
- Registry status
- 5
- Enrollment target
NCT01890824: Clinical Trial study, sponsored by Texas A&M University.
NCT01890824 is a clinical trial that was terminated before completion, run by Texas A&M University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01890824 was terminated before completion, sponsored by Texas A&M University.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Following chemotherapy, breast cancer patients primarily gain fat mass and lose muscle mass. Both depletion of muscle and an increase of fat mass in breast cancer patients are related to short survival, and decreased skeletal muscle mass and function may result in fatigue and inactivity, which contributes to fat mass changes and can be responsible for chemo-toxicity and increased mortality. The purpose of this study is to provide detailed insight in chemotherapy related changes in lipid metabolism and gut digestion and absorption of fat in breast cancer patients compared to matched healthy controls. This will provide required information that is necessary to implement new strategies to develop optimal nutritional regimen in breast cancer patients. The hypothesis is that chemotherapy in breast cancer is related to altered gut function and absorption and to increases in fat synthesis that lead to fat accumulation. In addition, we will examine the effect of cancer, chemotherapy, and gender by comparing fat digestion/absorption and fat metabolism of the breast cancer before and after chemotherapy, to aged matched healthy female and male controls.
Primary Outcome
changes in hepatic triglyceride synthesis before and after a meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-10 |
Why NCT01890824 stopped before completion
NCT01890824 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01890824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01890824 about?
NCT01890824 is a clinical study titled "Fat Metabolism Following Chemotherapy in Breast Cancer". Following chemotherapy, breast cancer patients primarily gain fat mass and lose muscle mass. Both depletion of muscle and an increase of fat mass in breast cancer patients are related to short survival, and decreased skeletal muscle mass and function may result in fatigue and inactivity, which contr...
What is the current status of trial NCT01890824?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2013-08. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT01890824?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia